Most recently, it's been recognized that conolidine and the above derivatives act about the atypical chemokine receptor three (ACKR3. Expressed in related areas as classical opioid receptors, it binds to a big range of endogenous opioids. Contrary to most opioid receptors, this receptor acts as a scavenger and isn't going to activate a next messeng